DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Paluch-Shimon S, Friedman E, Berger R. et al.
Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers.
Breast Cancer Res Treat 2016;
157: 157-165
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.